390 related articles for article (PubMed ID: 20124555)
1. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism.
Iliopoulos D; Drosatos K; Hiyama Y; Goldberg IJ; Zannis VI
J Lipid Res; 2010 Jun; 51(6):1513-23. PubMed ID: 20124555
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα.
Zhong D; Zhang Y; Zeng YJ; Gao M; Wu GZ; Hu CJ; Huang G; He FT
Lipids Health Dis; 2013 Mar; 12():32. PubMed ID: 23496987
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters.
Guo F; Huang C; Liao X; Wang Y; He Y; Feng R; Li Y; Sun C
Mol Nutr Food Res; 2011 Dec; 55(12):1809-18. PubMed ID: 22038976
[TBL] [Abstract][Full Text] [Related]
4. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats.
Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y
J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375
[TBL] [Abstract][Full Text] [Related]
5. miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1.
Guo Y; Yu J; Wang C; Li K; Liu B; Du Y; Xiao F; Chen S; Guo F
J Mol Endocrinol; 2017 Oct; 59(3):205-217. PubMed ID: 28667176
[TBL] [Abstract][Full Text] [Related]
6. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1.
Guo J; Fang W; Sun L; Lu Y; Dou L; Huang X; Sun M; Pang C; Qu J; Liu G; Li J
Oncotarget; 2016 Jun; 7(24):36207-36219. PubMed ID: 27166182
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.
Zhong D; Huang G; Zhang Y; Zeng Y; Xu Z; Zhao Y; He X; He F
Cell Signal; 2013 Jun; 25(6):1429-37. PubMed ID: 23499676
[TBL] [Abstract][Full Text] [Related]
8. Influences of sterol regulatory element binding protein-1c silencing on glucose production in HepG2 cells treated with free fatty acid.
Bai XP; Dong F; Yang GH; Zhang L
Lipids Health Dis; 2019 Apr; 18(1):89. PubMed ID: 30954075
[TBL] [Abstract][Full Text] [Related]
9. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
10. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
Luo L; Fang K; Dan X; Gu M
Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
[TBL] [Abstract][Full Text] [Related]
11. SREBP-1c overexpression induces triglycerides accumulation through increasing lipid synthesis and decreasing lipid oxidation and VLDL assembly in bovine hepatocytes.
Li X; Li Y; Yang W; Xiao C; Fu S; Deng Q; Ding H; Wang Z; Liu G; Li X
J Steroid Biochem Mol Biol; 2014 Sep; 143():174-82. PubMed ID: 24565561
[TBL] [Abstract][Full Text] [Related]
12. miR-23a/b-3p promotes hepatic lipid accumulation by regulating Srebp-1c and Fas.
Li L; Zhang X; Ren H; Huang X; Shen T; Tang W; Dou L; Li J
J Mol Endocrinol; 2021 Nov; 68(1):35-49. PubMed ID: 34723832
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling.
Seo MH; Lee J; Hong SW; Rhee EJ; Park SE; Park CY; Oh KW; Park SW; Lee WY
PLoS One; 2016; 11(12):e0166913. PubMed ID: 27907035
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
[TBL] [Abstract][Full Text] [Related]
18. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
19. Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress.
Liu JF; Ma Y; Wang Y; Du ZY; Shen JK; Peng HL
Phytother Res; 2011 Apr; 25(4):588-96. PubMed ID: 20925133
[TBL] [Abstract][Full Text] [Related]
20. Adaptations to excess choline in insulin resistant and Pcyt2 deficient skeletal muscle.
Taylor A; Schenkel LC; Yokich M; Bakovic M
Biochem Cell Biol; 2017 Apr; 95(2):223-231. PubMed ID: 28068143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]